Peroxisome Proliferator Receptor alpha Agonist class drugs
12 results
Fenofibrate (fenofibrate)
(Fenofibrate)Macleods Pharmaceuticals Limited
Usage: Fenofibrate is indicated as adjunctive therapy to diet for reducing low-density lipoprotein cholesterol, triglycerides, and apolipoprotein B while increasing high-density lipoprotein cholesterol in adults with primary hypercholesterolemia or mixed dyslipidemia and for treating severe hypertriglyceridemia.
Fenofibrate (fenofibrate)
(Fenofibrate)Alembic Pharmaceuticals Inc.
Usage: Fenofibrate is indicated as adjunctive therapy to diet for reducing LDL cholesterol, total cholesterol, triglycerides, and Apo B in adults with primary hypercholesterolemia and mixed dyslipidemia, as well as for managing hypertriglyceridemia in specific Fredrickson types. It is not suitable for type I hyperlipoproteinemia.
Fenofibrate (fenofibrate)
(Fenofibrate)A-S Medication Solutions
Usage: Fenofibrate tablet USP is indicated as adjunctive therapy to diet for reducing LDL-C, total cholesterol, triglycerides, and Apo B, and increasing HDL-C in adults with primary hypercholesterolemia or mixed dyslipidemia. It is also used for severe hypertriglyceridemia, although its effect on reducing pancreatitis risk is not well studied.
Fenofibrate (fenofibrate)
(Fenofibrate)AustarPharma, LLC
Usage: Fenofibrate tablets are indicated as adjunctive therapy to diet for adults with primary hypercholesterolemia or mixed dyslipidemia, reducing LDL-C and triglycerides while increasing HDL-C. They are also indicated for severe hypertriglyceridemia. However, fenofibrate does not reduce coronary heart disease morbidity in type 2 diabetes patients.
Fenofibrate (fenofibrate)
(FENOFIBRATE)Northwind Pharmaceuticals
Usage: Fenofibrate tablets are indicated as adjunctive therapy to diet for reducing LDL-C, total cholesterol, triglycerides, and apolipoprotein B, while increasing HDL-C in adults with primary hypercholesterolemia or mixed dyslipidemia, as well as for treating severe hypertriglyceridemia to mitigate pancreatitis risk.
Fenofibrate (fenofibrate)
(Fenofibrate)Bryant Ranch Prepack
Usage: Fenofibrate tablets are indicated as adjunctive therapy to diet for reducing LDL-C, total cholesterol, triglycerides, and Apo B, while increasing HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia. They also treat severe hypertriglyceridemia, particularly in diabetic patients.
Fenofibrate (fenofibrate)
(Fenofibrate)Alembic Pharmaceuticals Inc.
Usage: Fenofibrate tablets are indicated as adjunctive therapy to diet for reducing LDL-C, total cholesterol, triglycerides, and apolipoprotein B, while increasing HDL-C in adults with primary hypercholesterolemia or mixed dyslipidemia, and for treating severe hypertriglyceridemia. Limitations include lack of efficacy in reducing coronary heart disease risks in diabetic patients.
Fenofibric acid (fenofibric acid)
(Fenofibric Acid)Palmetto Pharmaceuticals, Inc
Usage: Fenofibric acid tablets are indicated as adjunctive therapy to diet for treating severe hypertriglyceridemia (≥ 500 mg/dL) and for reducing LDL-C, total cholesterol, triglycerides, and Apo B in primary hypercholesterolemia or mixed dyslipidemia patients. It does not reduce coronary heart disease risk in type 2 diabetes patients.
Fenofibric acid (fenofibric acid)
(Fenofibric acid)Micro Labs Limited
Usage: Fenofibric acid delayed-release capsules are indicated as adjunctive therapy to diet for reducing triglycerides in severe hypertriglyceridemia and for lowering LDL cholesterol, total cholesterol, triglycerides, and apolipoprotein B, while increasing HDL cholesterol in patients with primary hypercholesterolemia or mixed dyslipidemia.
Gemfibrozil (gemfibrozil)
(Gemfibrozil)Cadila Pharmaceuticals Limited
Usage: Gemfibrozil tablets are indicated as adjunctive therapy to diet for treating very high triglyceride levels (Types IV and V hyperlipidemia) to reduce pancreatitis risk and for lowering coronary heart disease risk in Type IIb patients who do not respond to lifestyle changes and other medications.